Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
...And the viral load reductions on the EIND patients was what exactly?
How do you go from a phase 1 to a phase 3 with a handful of people. We have 10 years of results and get dragged along.
Aren't they in phase 1? They mentioned they are looking forward to starting phase 3 this month...
I'm showing back to red
Thanks, I'll take any green movement. Let's start the climb
How are we looking in the German markets?
This is what we are up against, they will even go after other large BP
If they go head to head with other BP's. Do you really think they're going to allow us, a small time company to play in their sandbox? We're not going to be able to play until we have a BP partnership. NO WAY we get there alone, at least not anytime soon.
https://www.statnews.com/pharmalot/2020/07/13/gilead-viiv-hiv-glaxo-uk/
That's my thoughts. We submitted, they pushed back, we complied, then 2 months later this...
I just don't get how they now pushed back. We submitted, they then asked for more data, which we provided, then they accepted the BLA. Now months later they want more data?
First paragraph
Thank you!
I hope we get some updates on concrete material that the company is moving forward. i.e. the start of any of the trials Mexico, Brazil, UK, Nash.
IMO the Mexico trial should be a no brainier it will be quick, 25 patients?
Thanks for the update. Where are our new levels of support? It looks like the RSI has now fallen under 50 as well.
Great first post, thank you for stopping by, I wish you the best in your investing endeavors.
Almost 8m vol in an hour and a half. We didn't do 8m all day yesterday
I don't think that was the case, they would have announced that he was speaking at this event prior.
I wonder if that was the market moving news that was talked about last week?
That must be nice... Ugh someday
NP has mentioned several times that Big Pharma and Big Media are awaiting the covid trial results. Who knows what that will bring once released. Also we are expecting out PUFDA date the end of this week. Any Big Pharma who partners/buys us out will make sure HIV is going to get approved, they have lobbying power. I'm sure there are some very interested parties. That being said, it could go back and forth between houses best offer wins.
The last few time Nader as spoke, he did mention BO. On the proactive video when talking about the shared drive the 2 examples he gave were for licensing or buyout, not partnership. Then again on the Dr. Been interview.
Maybe we won't get a buyout but sell off individual indications? Sell Covid, sell HIV. Those would be more realistic numbers, and the reason we now have 3 labels? Vyrologix, Immuvance, and Leronlimab?
Why not just buy now?
Durning the phase 2&3 trials? There may be patients who have died in phase 3 per np, but we don't know the cause, whether it be because they received the placebo, do lack of care, or an underlying condition. This far with 900+ patients there has been no SAEs. Google pump and dump "quoted" np saying death is now an SAE for leronlimab
I'm sorry I'm not following?
The trials have yet to be unblinded, we don't know why the patients died. Whether it be they received the placebo, or an underlying health condition.
Did he mention why the change from NYSE?
You're not getting it. Our approval will take away revenue from the big pharma. Our drug is clearly better, so once it's approved and out there, who's going to want to use the 2nd best? Big pharma as lined the pockets of the government. Will it be approved, most likely when is the question. I really hope it does for mankind. But life isn't fair, and it's the people who have the money that make the rules. I hope I'm wrong and we're in for a HUGE surprise, I don't see that happening until we partner with BP.
Whether they know or not is not the concern. Whether they allow us to proceed is. Remdesivir trial primary end point was moved, and they they allowed EUA. Clearly it doesn't work, it doesn't reduce viral load. Giliad spent $2m in Q1 on lobbying. It costs $$$ to make things happen, we have 10+ years of a clean safety record with HIV patients AND, we reduce viral load. Why not give us EUA already???
The WHO needs to be spoon fed our trial results. With their thumbs up we will no longer be in the shadows.
I would like to think that. But with what has transpired lately, the government is up for sale, and CYDY just doesn't have the pocket change. Maybe someone will finally get it, but who knows. This week should be VERY telling. We're ready to go, some country will benefit, for that I am sure.
If it doesn't get approved, the next PR is 1st person injected in phase 3 trial in Mexico
Brazil needs it the most right now, they'll surpass us soon, which is sad.
Hey I'll take converted Pesos, if the US wants to play games. 25 patients will go real quick.
How would they be in phase 3?
Humanigen announces data on the first clinical use of lenzilumab, the proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor, in 12 COVID-19 patients.
Well tomorrow is the 4th of July, and I do enjoy a spectacular firework show.
Any guesses on what the news may be about???
From what I've read, this mutated stain is actual more infectious, you don't get any sicker, but are more likely to get it. This may be the perfect storm for us. When Remdesivir was approved the cases were around 24k/day, now were over 50k/day and climbing. The US bought the whole supply of Remdesivir, now they need more medicine, medicine that works. LERONLIMAB... We have over 10 years of safety, and based on all the EIND use, it works. The Gov can't ignore it forever, I feel now is our time. The US is out of options.
I don't have Twitter, but if someone could ask him what the status of BP's peer review submission is, that would be fantastic.
New Trademark:
But look who it used to belong to.
What does that mean near term?
...and said?